2025年3月25日，爱思唯尔正式发布2024年“中国高被引学者”（Highly Cited Chinese Researchers）年度榜单。Advances in Radiotherapy & Nuclear Medicine ...

鼻咽癌高发于中国，新发病例占世界47%。马骏教授团队提出的“诱导化疗+同期放化疗”已经被国际指南采纳并全球应用。尽管诱导化疗可以使90%的患者肿瘤体积显著缩小，但是目前国际专家共识仍推荐不管化疗后肿瘤体积如何缩小，放疗的范围均需要包括化疗前的肿瘤范围 ...

Comparison of electron- and proton-based FLASH radiotherapy reveals remarkable similarity in reducing acute skin damage ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Early toxicities associated with a 3-week hypofractionated radiotherapy regimen do not raise initial safety concerns in women ...

Around 50–90% of brain tumor patients that survive at least 6 months after radiotherapy experience some form of cognitive ...

The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

在肿瘤治疗的领域中，软组织肉瘤（Soft Tissue Sarcomas，STS）是一类较为罕见却极具挑战性的恶性肿瘤。它起源于肌肉、脂肪、神经和血管等结缔组织，虽然在所有成人癌症中占比不到 1%，但其复杂的生物学特性和多样的组织学亚型，使得治疗困难重重。超过半数的 STS 患者在确诊时已处于晚期，多伴有转移或局部晚期疾病，预后普遍较差。

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

Actinium Pharmaceuticals Inc. has unveiled ATNM-400, a novel non-PSMA-targeting, first-in-class radiotherapy for prostate cancer utilizing the Actinium-225 (Ac-225) radioisotope.

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.